# HanchorBio and Aston Sci Join Forces to Unlock the Potential of Next-Generation Immunotherapy Through Cancer Vaccine Combinations

- Source: PR Newswire
- Published: 2026-10-22T10:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/hanchorbio-and-aston-sci-join-forces-to-unlock-the-potential-of-next-generation-immunotherapy-through-cancer-vaccine-combinations-302916658.html
- Canonical: https://groundlevelnews.com/story/hanchorbio-and-aston-sci-join-forces-to-unlock-the-potential-of-next-g-18581d/

Strategic collaboration pairs HCB101 (macrophage CD47-SIRPα blockade) with Aston Sci's Phase 2 HER2-directed DNA vaccine (AST-301) to drive durable, dual innate/adaptive antitumor immunity Initial studies focus on gastric and breast cancers; expands to evaluate AST-301 and investigational...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire._